Information Technology Reference
In-Depth Information
Figure 34. Number of doses in a year for Boniva® monthly at 150 mg dose
Figure 35. Number of doses for the drug Evista® at 60 mg per dose
osteoporosis or postmenopausal osteoporosis), V17.81 (Osteoporosis), 733.02 (Idiopathic osteoporosis),
733.03 (Disuse osteoporosis), 733.0 (Osteoporosis), and 733.00 (Osteoporosis, unspecified). However,
there are other primary patient conditions listed for Actonel® that include 714 (Rheumatoid arthritis and
other inflammatory polyarthropathies), 715 (Osteoarthrosis and allied disorders), 716 (Other and unspeci-
fied arthropathies), 718 (Other derangement of joint), and 719 (Other and unspecified disorders of joint).
Actonel® is not approved for arthritis and is not considered effective for its treatment. It is possible that
arthritis is primary and osteoporosis is secondary. However, 733 is not listed as a secondary ICD9 code
Search WWH ::
Custom Search